Market size, growth to 2033 and clinical trials, side by side.
The US is the bigger Coenzyme Q10 market: $210 Mn against $40 Mn in 2023, about 5.3 times as large.
Canada grows faster: 9% a year, against 7%. The gap still grows from $170 Mn to $318 Mn by 2033.
Clinical research: 21 active trials in the US, 3 in Canada.
| Measure | ||
|---|---|---|
| Market size, 2023 | $210 Mn | $40 Mn |
| Market size, 2033 projected | $413 Mn | $95 Mn |
| Growth a year (CAGR) | 7% | 9% |
| Money added, 2023–2033 | $203 Mn | $55 Mn |
| Share of the world market | 42% | 8% |
| Size rank of 24 countries | #1 | #3 |
| Market per person, 2023 | $0.61 | $0.96 |
| Active clinical trials | 21 | 3 |
| Full report | US report | Canada report |
US Canada · values between 2023 and 2033 are projected from the 2023 size and the CAGR.
The US is the bigger Coenzyme Q10 market: $210 Mn against $40 Mn in 2023, about 5.3 times as large.
Canada grows faster: 9% a year, against 7%. The gap still grows from $170 Mn to $318 Mn by 2033.
Sources: market size and growth: Acuitas Health Analytics research (2023 base year, forecasts to 2033). Trials: ClinicalTrials.gov (fetched 10 Nov 2026); found by search words, so counts are a guide. Population: World Bank.